Good afternoon! All eyes are on Novo Nordisk and Eli Lilly again as Wall Street looks for signs that they can address one of the biggest hurdles they faced last year. Neither company has enough supply to meet the insatiable demand for their weight loss and diabetes drugs. One month into 2024, the two drugmakers still haven't...
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan McDermid | ReutersEli Lilly on Tuesday said its highly popular drug used for weight loss and diabetes showed promise as a treatment for fatty liver disease in a midstage...
Akio Toyoda, Chairman of Toyota Motor Corporation.Yoshikazu Tsuno | Gamma-rapho | Getty ImagesToyota Motor is investing $1.3 billion in a Kentucky plant to produce a new all-electric, three-row SUV for the U.S. market, the company said Tuesday.The vehicle is expected to go into production between late 2025 and early...
Check out the companies making headlines in midday trading. Palantir — Shares of the data analytics provider surged more than 24% after the company reported $608.4 million in revenue for the quarter, versus the $602.4 million expected by analysts surveyed by LSEG, formerly known as Refinitiv. Guidance for 2024...
Epoxydude | Fstop | Getty ImagesCredit card delinquencies surged more than 50% in 2023 as total consumer debt swelled to $17.5 trillion, the New York Federal Reserve reported Tuesday.Debt that has transitioned into "serious delinquency," or 90 days or more past due, increased across multiple categories during the year,...
SUMA Wealth now has $2.2 million in new capital to continue developing financial tools, content and live and digital activations for young U.S. Latinos to build wealth. Radicle Impact led the investment with participation from Vamos Ventures, OVO fund and American Heart Association Impact fund. They join investors from previous...
